Friday, July 31, 2026

Nuclear GRANDSTANDING: North Korea’s Pathetic Deception Exposes Their VAST Lie To The Entire World

North Korea's hypersonic missile claim may be deceptive; analysis shows recent launches resemble conventional ballistic missiles.

Hyundai’s Ioniq 5: The Future of Autonomous Driving in America Revealed!

Hyundai's CEO highlights future mobility with autonomous vehicles, hydrogen energy, and robotics to enhance production and urban transport.

North Korea’s Ideological Construction: Key to Strengthening the Party’s Revolution in 2026?

North Korea prioritizes ideological construction, emphasizing its role in party development and political leadership during the 9th Congress.

Tag: Vegzelma

How Celltrion’s Omlyclo Achieved 16% Market Share in Europe: A Game-Changer for Biologics

Celltrion's biosimilars gain market share in Europe, with Omlyclo leading in Spain and Vegzelma maintaining strong presence amid competition.

Bevacizumab Breakthrough: How Celltrion’s Vegzelma Secured Coverage in Major U.S. PBMs

Celltrion's Vegzelma gains preferred status with major U.S. PBMs, enhancing prescription access and boosting market share.

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

Top News

- Our Sponsors Ad -

Follow us